Metsera

Metsera Operating Expenses

Delisted

The Total Operating Expenses of Metsera (MTSR) as of Nov 4, 2026 is 134.31 M USD. In the previous year, Total Operating Expenses was 30.61 M USD — a change of 338.85% (higher).

Operating Expenses

134.31 MUSD

YoY

338.85%

Last updated:

Total Operating Expenses of Metsera is 2024 134.31 M USD. Total Operating Expenses of Metsera was 2023 30.61 M USD. It decreases by 338.85% higher compared to the previous year.

The Metsera Operating Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Expenses
Date
Operating Expenses
Jan 1, 2022
259,000.00 USD
Jan 1, 2023
30.61 M USD
Jan 1, 2024
134.31 M USD
The Metsera Operating Expenses history
YEAROperating ExpensesYoY
134.31 MUSD+338.85%
30.61 MUSD+11,716.99%
259,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Metsera Stock analysis

What does Metsera do? Metsera Inc. is a clinical stage biopharmaceutical company based in New York City, operating in the Health Care sector with a focus on Biotechnology. The company develops next-generation injectable and oral nutrient stimulated hormone (NuSH) analog peptides for treating obesity and related conditions. Utilizing its proprietary MINT peptide library, HALO half-life extension platform, and MOMENTUM oral delivery system, Metsera has a pipeline including MET-097i, MET-233i, and MET-224o, targeting various obesity treatments with differentiated approaches. Listed on 31 January 2025, the company employs 82 staff. Metsera is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Metsera stock

Total Operating Expenses of Metsera is 134.31 M USD in 2024.

Total Operating Expenses of Metsera changed from 30.61 M USD to 134.31 M USD, representing a 338.85% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Operating Expenses Metsera since 2006 – with annual values, charts, and detailed analysis.

Operating expenses are the costs incurred in the normal course of business operations, including COGS, SG&A, R&D, and depreciation.

Total Operating Expenses's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Operating Expenses's Metsera historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Metsera

All Key Metrics — Metsera